These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23999369)

  • 1. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Abnormal bone metabolism in pulmonary diseases].
    Hirai T
    Clin Calcium; 2013 Sep; 23(9):1321-6. PubMed ID: 23999369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic intervention of rheumatoid arthritis bone loss].
    Ono K; Ohashi S; Tanaka S
    Clin Calcium; 2013 Sep; 23(9):1345-52. PubMed ID: 23999372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
    Hayakawa N; Suzuki A
    Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures.
    Schacht E; Richy F; Reginster JY
    J Musculoskelet Neuronal Interact; 2005; 5(3):273-84. PubMed ID: 16172518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucocorticoid and Bone. Fracture risk of steroid-induced osteoporosis].
    Fujiwara S
    Clin Calcium; 2014 Sep; 24(9):1295-300. PubMed ID: 25177001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary osteoporosis or secondary contributors to bone loss in fracture. causes and pathophysiology of secondary osteoporosis].
    Yamauchi M; Sugimoto T
    Clin Calcium; 2013 Sep; 23(9):1251-7. PubMed ID: 23999359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary diseases and bone].
    Hirai T
    Clin Calcium; 2013 Feb; 23(2):237-42. PubMed ID: 23354091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Effects of oxidative stress on bone metabolism].
    Notsu M; Yamaguchi T
    Clin Calcium; 2013 Sep; 23(9):1285-92. PubMed ID: 23999364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues in designing and testing a "cure" for osteoporosis.
    Cummings S
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):408. PubMed ID: 15758283
    [No Abstract]   [Full Text] [Related]  

  • 11. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Bone metabolic disorders in patients with diabetes mellitus].
    Yamamoto M
    Clin Calcium; 2013 Sep; 23(9):1327-35. PubMed ID: 23999370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study.
    Jørgensen NR; Schwarz P; Holme I; Henriksen BM; Petersen LJ; Backer V
    Respir Med; 2007 Jan; 101(1):177-85. PubMed ID: 16677808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Metabolic bone disease and fracture induced by drugs].
    Suzuki H
    Clin Calcium; 2013 Sep; 23(9):1307-12. PubMed ID: 23999367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA; Hamdy NA
    Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis and bone health in patients with lung disease.
    Bolster MB
    Clin Chest Med; 2010 Sep; 31(3):555-63. PubMed ID: 20692547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-induced osteoporosis.
    Berris KK; Repp AL; Kleerekoper M
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological treatment of other types of secondary osteoporosis].
    Okazaki R
    Nihon Rinsho; 2015 Oct; 73(10):1740-5. PubMed ID: 26529940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical treatment for osteoporosis with pulmonary disorders-from a viewpoint of an endocrinologist-.].
    Yasoda A
    Clin Calcium; 2016; 26(10):1475-1481. PubMed ID: 27666696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component.
    Graat-Verboom L; Spruit MA; van den Borne BE; Smeenk FW; Martens EJ; Lunde R; Wouters EF;
    Respir Med; 2009 Aug; 103(8):1143-51. PubMed ID: 19304474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis risk in premenopausal women.
    Vondracek SF; Hansen LB; McDermott MT
    Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.